Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in those with ulcerative colitis ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

of golimumab were able to see improvements in ulcerative colitis by week 30 of treatment. This was compared to 15.6% of ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...